Bioline RX Ltd Sponsored ADR share price logo

Bioline RX Ltd Sponsored ADR

NASDAQ: BLRX

$2.43

-0.05

(-2.02%)

as on

Bioline RX Ltd Sponsored ADR Stock Performance

as on September 23, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.42
    $2.60
    downward going graph

    0.41%

    Downside

    7.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.15
    $4.56
    downward going graph

    11.52%

    Downside

    87.65%

    Upside

    downward going graph

Bioline RX Ltd Sponsored ADR share price movements today

Previous Close
$2.48
Open
$2.56
Volume
137.8K
Market Cap
$12.1M
Day's Low - High
$2.42 - $2.60
52 Week Low - High
$2.15 - $4.56

Bioline RX Ltd Sponsored ADR Historical Returns

1 Month Return
-11.74 %
3 Month Return
-23.46 %
1 Year Return
-35.92 %
3 Year Return
-97 %
5 Year Return
-97.73 %

Bioline RX Ltd Sponsored ADR Stock Fundamentals & Key Indicators

Check Bioline RX Ltd Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.1M

EPS (TTM)

-3.14

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.2

Return On Equity TTM

-55.27%

Bioline RX Ltd Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bioline RX Ltd Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Bioline RX Ltd Sponsored ADR image
Bioline RX Ltd Sponsored ADR
Buy$12.1M-97.73%NA0.00%0.00%
Moderna image
Moderna
Neutral$61.5B-60.76%-19.3-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.8B177.16%29.3586.04%0.00%
Regeneron image
Regeneron
Buy$80.8B23.35%18.4884.86%0.47%

Stock Returns calculator for Bioline RX Ltd Sponsored ADR Stock including INR - Dollar returns

The Bioline RX Ltd Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioline RX Ltd Sponsored ADR investment value today

Current value as on today

₹67,965

Returns

-₹32,035

(-32.03%)

Returns from Bioline RX Ltd Sponsored ADR Stock

-₹37,209 (-37.21%)

Dollar Impact

₹5,175 (+5.17%)

Analyst Recommendation on Bioline RX Ltd Sponsored ADR Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Bioline RX Ltd Sponsored ADR. Average target price of $26

Indian Investors' Interest in Bioline RX Ltd Sponsored ADR Stock

Search interest for Bioline RX Ltd Sponsored ADR Stock has increased by 288% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:288% versus previous 30 day period

Bioline RX Ltd Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
6
5
4
11
0
0
0
0
0
0
Gross Profit
5
4
4
5
0
0
0
0
0
0
Operating Income
-4
-5
-5
-4
-2
-2
-2
-3
-3
-3
EBITDA
1
3
-3
3
5
-3
0
-1
-2
-3
Interest Expense
0
2
1
4
0
0
0
0
0
0
Depreciation
0
0
0
1
0
0
0
0
0
0
Income Before Tax
0
0
-5
-3
5
-3
0
-2
-2
-4
Income Tax Expense
5
-
-
-
-
-
-
-
-
-
Net Income
0
0
-5
-3
5
-3
0
-1
-2
-3
Net Profit Margin
-10.15%
8.97%
-117.78%
-27.13%
2010.59%
-1296.05%
-228.81%
-713.92%
-541.09%
-1029.25%

Bioline RX Ltd Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
4
28
1
Gross Profit
0
0
0
0
0
0
0
1
19
0
Operating Income
-16
-25
-25
-28
-22
-24
-29
-49
-20
-10
EBITDA
-15
-24
-22
-22
-27
-25
-22
-57
3
0
Interest Expense
0
0
0
1
1
0
2
2
9
1
Depreciation
-
0
0
0
0
0
0
1
4
0
Income Before Tax
-15
-24
-22
-25
-30
-27
-24
-60
-9
-2
Income Tax Expense
0
0
2
1
0
1
-4
0
-
-
Net Income
-15
-24
-22
-25
-30
-27
-24
-60
-9
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-1262.79%
-31.86%
-99.58%

Bioline RX Ltd Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-5
-3
5
-3
0
-1
-2
-3
Operating Cash Flow
-11
-9
-8
-2
0
-2
-3
-2
-3
Investing Cash Flow
-8
10
11
-8
-3
3
0
2
6
Financing Cash Flow
23
-1
-1
9
1
0
-1
-1
-1
Change in Cash
3
0
1
-1
-1
0
-4
0
2

Bioline RX Ltd Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-22
-25
-30
-27
-24
-60
-9
-1
Operating Cash Flow
-20
-24
-22
-23
-23
-26
-22
-43
-8
Investing Cash Flow
-15
9
5
16
-38
4
1
29
-8
Financing Cash Flow
38
13
19
17
57
20
15
20
8
Change in Cash
2
-1
1
11
-3
-2
-6
6
-7

Global Institutional Holdings in Bioline RX Ltd Sponsored ADR

Funds
Holdings
Citadel Advisors Llc
0.31%
CapTrust Financial Advisors
0%
BNP Paribas Arbitrage, SA
0.04%
Values First Advisors Inc
0%
XTX Topco Ltd
0.23%
See all

Bioline RX Ltd Sponsored ADR News & Key Events

  • img

    Today's Timeline - 31 August

    Mon, 04:40 PM

    -

    BioLineRx reports Q2 EPS and revenue, with ongoing GLIX1 trial progress.

    Mon, 05:17 PM

    -

    BioLineRx reports Q2 results, highlighting GLIX1 trial advancements and financials.

    Mon, 07:53 PM

    -

    BioLineRx announces details of ADS and warrant funding round.

  • img

    Today's Timeline - 31 August

    Mon, 08:27 PM

    -

    BioLineRx raises $3.75 million through registered direct offering and warrants.

    Tue, 05:37 AM

    -

    BioLineRx reports progress in GLIX1 oncology program, despite wider losses and flat revenue.

Insights on Bioline RX Ltd Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 73.0% return, outperforming this stock by 170.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 551.1% return, outperforming this stock by 587.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, BLRX stock has moved down by -97.0%

About Bioline RX Ltd Sponsored ADR

BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational product, Motixafortide, a peptide, has successfully concluded pivotal Phase 3 clinical trials for mobilizing stem cells in autologous transplants, and Phase 2a trials targeting pancreatic cancer. This compound is currently progressing through Phase 2 studies for metastatic pancreatic adenocarcinoma and Phase 1b trials for acute respiratory distress syndrome linked to COVID-19 and other viral infections. Additionally, Motixafortide is being investigated for its therapeutic potential in solid tumors and acute myeloid leukemia. The company's pipeline also includes AGI-134, an immuno-oncology agent presently undergoing Phase 1/2a clinical evaluations for various solid tumors. Furthermore, BioLineRx is advancing BL-5010, a custom-designed, proprietary pen-like device intended for the non-surgical removal of skin lesions. BioLineRx maintains strategic alliances, notably a collaboration with MSD in the domain of cancer immunotherapy, and an agreement with MD Anderson Cancer Center to explore Motixafortide combined with KEYTRUDA (pembrolizumab) for pancreatic cancer. They also have a licensing deal with Perrigo Company plc for the over-the-counter sale of BL-5010.
OrganisationBioline RX Ltd Sponsored ADR
HeadquartersModi’in Technology Park, Hevel Modi'in, HM, 7177871, IL
IndustryBiotechnology
CEOPhilip A. Serlin
E-voting on sharesClick here to vote

Key Management of Bioline RX Ltd Sponsored ADR

Name

Title

Mr. Philip A. Serlin CPA, M.B.A.

Chief Executive Officer

Ms. Mali Zeevi CPA

Chief Financial Officer

Dr. Ella Sorani Ph.D.

Chief Development Officer

Mr. John Lacey

Head of Corporate Communications & Investor Relations

Mr. Raziel Fried

Treasurer & Budgetary Control Director

FAQs

What is Bioline RX Ltd Sponsored ADR share price today?

Bioline RX Ltd Sponsored ADR share price today is $2.43 as on at the close of the market. Bioline RX Ltd Sponsored ADR share today touched a day high of $2.60 and a low of $2.42.

What is the 52 week high and 52 week low for Bioline RX Ltd Sponsored ADR share?

Bioline RX Ltd Sponsored ADR share touched a 52 week high of $4.56 on and a 52 week low of $2.15 on . Bioline RX Ltd Sponsored ADR stock price today i.e. is closed at $2.43,which is 46.71% down from its 52 week high and 13.02% up from its 52 week low.

What is Bioline RX Ltd Sponsored ADR's market capitalisation today?

Bioline RX Ltd Sponsored ADR market capitalisation is $0.00T as on .

How to invest in Bioline RX Ltd Sponsored ADR Stock (BLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bioline RX Ltd Sponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioline RX Ltd Sponsored ADR Shares that will get you 0.6173 shares as per Bioline RX Ltd Sponsored ADR share price of $2.43 per share as on September 23, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bioline RX Ltd Sponsored ADR Stock (BLRX) from India?

Indian investors can start investing in Bioline RX Ltd Sponsored ADR (BLRX) shares with as little as ₹95.58 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.80 in Bioline RX Ltd Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Bioline RX Ltd Sponsored ADR share’s latest price of $2.43 as on September 23, 2026 at 1:29 am IST, you will get 4.1152 shares of Bioline RX Ltd Sponsored ADR. Learn more about fractional shares .

What are the returns that Bioline RX Ltd Sponsored ADR has given to Indian investors in the last 5 years?

Bioline RX Ltd Sponsored ADR stock has given -97.73% share price returns and 29.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?